Skip to content

Family Members Affected by Substance Use Disorder - a Follow-up Study

Family Members Affected by Substance Use Disorder: How do They Cope and What Are Their Expressed Needs for Support?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05665582
Enrollment
271
Registered
2022-12-27
Start date
2016-01-01
Completion date
2017-12-31
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burden

Brief summary

The present study registration relates to a quantitative sub-study of a larger mixed method study, including also a qualitative sub-study. Together, these investigations will provide complementary insights. The quantitative study is a follow-up study of close relatives (\> 16 years) of patients in treatment for substance use disorder (SUD) who participated in a group-based 4-day psychoeducational program.

Detailed description

The study is a follow-up study of close relatives (\> 16 years) of patients in treatment for SUDs who participated in a group-based 4-day psychoeducational program. The investigators will examine whether the family intervention in the specialized treatment services has benefits in terms of typical patient reported outcomes; physical complaints, psychological functioning, family functioning and QoL. The data collection has been finalized in 2017.

Interventions

OTHERFamily program

A 4-day psychoeducational family program.

Sponsors

Sorlandet Hospital HF
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All participants in a family program

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Caregiver burdenChanges from baseline to the 3 months follow-upChanges in Codependency symptomatology measured with the Composite Codependency Scale (CCS). Participants indicate the extent to which they agreed with each statement on a scale of 1 (strongly disagree) to 5 (strongly agree).
Family functioningChanges from baseline to the 3 months follow-upChanges in the general family functioning subscale (GFFS). Respondents complete 12 items with a four-point response scale (1 = strongly agree, 4 = strongly disagree). A mean score is computed and a higher score indicated greater family dysfunction.

Secondary

MeasureTime frameDescription
Mental distressChanges from baseline to the 3 months follow-upChanges in the the Hopkins Symptom Checklist (HSCL) 10-item version, which is used to measure mental distress. This 10-item index maps symptoms of anxiety (4 items) and depression (6 items) on 4-point Likert-type scales ranging from not bothered at all (1) to extremely bothered (4). The global severity index (GSI) constitutes the average of all items, with the highest score indicating greater symptom severity during the past week.
Physical complaintsChanges from baseline to the 3 months follow-upChanges in physical complaints, measured on a 10-point ordinal scale (scaled 0 - 10) with higher score indicating more complaints.
Well-being / quality of lifeChanges from baseline to the 3 months follow-upChanges in Quality of Life measured with the QoL-5 scale (5 items). Responses are scored on a five-point scale ranging from very poor to very good QoL and then recoded into a decimal scale from 0.1 to 0.9, where 0.9 is the highest/best score and 0.1 the lowest/worst

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026